Ontology highlight
ABSTRACT: Background
Previous studies indicate that men experience frustration and uncertainty when confronted with an elevated prostate specific antigen (PSA) test and during further diagnostics for prostate cancer. The novel Stockholm3 test is an algorithm-based test that combines plasma protein biomarkers, genetic markers and clinical variables in predicting the risk of PCa. The test was introduced in a western part of Norway as a new tool for detecting prostate cancer. This study aimed to explore and compare men's perception of information and possible experience of distress between a PSA group and a Stockholm3 group during the diagnostic phase of prostate cancer.Methods
This study is a part of the trailing research evaluating the impact of the change from PSA to Stockholm3. It i
SUBMITTER: Sondergaard MEJ
PROVIDER: S-EPMC9526317 | biostudies-literature | 2022 Sep
REPOSITORIES: biostudies-literature